Article
[Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012].
Enfermedades infecciosas y microbiologia clinica - 1 Jun 2012
Blasco Antonio Javier, Arribas José Ramón, Boix Vicente, Clotet Bonaventura, Domingo Pere, González-García Juan, Knobel Hernando, López Juan Carlos, Llibre Josep M, Lozano Fernando, Miró José M, Podzamczer Daniel, Santamaría Juan Miguel, Tuset Montserrat, Zamora Laura, Lázaro Pablo, Gatell Josep M
Abstract excerpt
INTRODUCTION: The GESIDA and National AIDS Plan panel of experts propose «preferred regimens» of antiretroviral treatment (ART) as initial therapy in HIV infected patients for 2012. The objective of this study is to evaluate the costs and the efficiency of initiating treatment with these «preferr...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.